Measurement of in-vivo pulmonary vascular impedance in two animal models of pulmonary hypertension

被引：0
|
作者：
Hunter, Kendall S. [1 ]
Lanning, Craig J. [1 ]
Albietz, Joseph A.
Oka, Masahiko
Fagan, Karen A.
Stenmark, Kurt R.
Shandas, Robin [1 ]
机构：
[1] Childrens Hosp UCHSC, Dept Pediat, Div Cardiol, Denver, CO 80218 USA
来源：
PROCEEDING OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2007 | 2007年
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [41] PULMONARY VASCULAR REMODELING IN PULMONARY-HYPERTENSION
    HEATH, D
    [J]. ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY, 1992, 4 (03): : 205 - 211
  • [42] The Effects of Vasodilators in Pulmonary Hypertension Pulmonary Vascular or Peripheral Vascular?
    Rich, Stuart
    [J]. CIRCULATION-HEART FAILURE, 2009, 2 (02) : 145 - 150
  • [43] The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
    Sakao, Seiichiro
    Voelkel, Norbert F.
    Tatsumi, Koichiro
    [J]. EUROPEAN RESPIRATORY REVIEW, 2014, 23 (133): : 350 - 355
  • [44] How valid are animal models to evaluate treatments for pulmonary hypertension?
    Campian, Maria E.
    Hardziyenka, Maxim
    Michel, Martin C.
    Tan, Hanno L.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (06) : 391 - 400
  • [45] The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure
    Boucherat, Olivier
    Agrawal, Vineet
    Lawrie, Allan
    Bonnet, Sebastien
    [J]. CIRCULATION RESEARCH, 2022, 130 (09) : 1466 - 1486
  • [46] The Role of Fatty Acid Oxidation in Animal Models of Pulmonary Hypertension
    Lee, M. H.
    Sanders, L.
    Kumar, R.
    Hernandez-Saavedra, D.
    Yun, X.
    Ford, J. A.
    Perez, M.
    Mickael, C.
    Gandjeva, A.
    Koyanagi, D.
    Harral, J.
    Irwin, D.
    Kassa, B.
    Eckel, R.
    Shimoda, L. A.
    Graham, B. B.
    Tuder, R. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [47] Animal models of pulmonary hypertension due to left heart disease
    Shao-Fei Liu
    Yi Yan
    [J]. Animal Models and Experimental Medicine, 2022, 5 (03) : 197 - 206
  • [48] How valid are animal models to evaluate treatments for pulmonary hypertension?
    Maria E. Campian
    Maxim Hardziyenka
    Martin C. Michel
    Hanno L. Tan
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 373 : 391 - 400
  • [49] Different tryptophan-kynurenine metabolism profiles in human pulmonary arterial hypertension and animal models of pulmonary hypertension
    Cai, Z.
    Klein, T.
    Tu, L.
    Geenen, L. W.
    Tian, S.
    Van der Ley, C.
    Van Faassen, M.
    Kema, I
    Van den Bosch, A. E.
    De Rijke, J. B.
    Reiss, I. K. M.
    Dunker, D. J.
    Boomars, K. A.
    Guignabert, C.
    Merkus, D.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 3814 - 3814
  • [50] Application of animal models in experimental medicine on the basis of pulmonary hypertension
    Sztuka, Katarzyna
    Orszulak-Michalak, Daria
    Jasinska-Stroschein, Magdalena
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 686 - 700
12345